The Zacks Analyst Blog Highlights: MasterCard, Visa, Heartland Payment Systems, Total System Services and Perrigo
CHICAGO, Feb. 13, 2013 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include MasterCard Inc. (NYSE: MA), Visa Inc. (NYSE: V), Heartland Payment Systems Inc. (NYSE: HPY), Total System Services Inc. (NYSE: TSS) and Perrigo Company (Nasdaq: PRGO).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513
Here are highlights from Tuesday's Analyst Blog:
MasterCard Deploys Excess Capital
Following a better-than-expected 2012 financial results, last week MasterCard Inc. (NYSE: MA) announced higher yield to its shareholders through share buybacks and dividend increment. This further raised investors' confidence in this Zacks Rank #3 (Hold) stock.
Accordingly, MasterCard declared a 100% hike in quarterly dividend of 30 cents per share to 60 cents. The increased dividend will be payable on May 9, 2013 to shareholders of record as on Apr 9, 2013. Based on 124 million shares outstanding at the end of Jan 2013, the company should be able to return about $75 million to its shareholders through dividends.
The latest hike takes the annual dividend to $2.40 per share from the previous $1.20 a share. This aggregates to a dividend yield of 0.46%, based on Monday's closing price of $520.85, up from the prior yield of 0.23%.
Adding to the wealth of its shareholders, the board of MasterCard also sanctioned a new share repurchase program worth $2.0 billion, which will be effective once the buybacks under the previous program worth $1.5 billion, announced in Jun 2012, is completed. Overall, the company bought back 4.1 million shares worth $1.7 billion in 2012. As of Jan 25, MasterCard had $440 million of stock available for buybacks under the prior authorization.
The decision to amplify the shareholders' return was supported by the company's increased cash flow in 2012 along with its ability to generate higher cash flow and earnings in 2013 as well. MasterCard's operating cash flow improved 9.8% over 2011 to $2.95 billion in 2012.
With no long-term debt and modest growth in expense amid better pricing, increased number of processed transactions and strong gross dollar value (GDV) growth, we believe that the company is well-fortified to accelerate growth from the improving card industry dynamics in 2013, primarily through expansion in the developing economies. This also justifies MasterCard's aim of returning higher value from the stock.
Last week, MasterCard reported fourth-quarter 2012 operating earnings per share of $4.86, which modestly beat the Zacks Consensus Estimate of $4.79 and the year-ago quarter's earnings of $4.03. Operating net income for the reported quarter stood at $605 million, up 17.7% from $514 million in the prior-year quarter. Operating net income also increased 15.5% to $2.77 billion in 2012 from $2.40 billion in 2011.
Simultaneously, last week close peer – Visa Inc. (NYSE: V), a Zacks Rank #2 (Buy) stock – sanctioned a new share repurchase program worth $1.75 billion, which is set to expire by Jan 2014. In Oct 2012, Visa also hiked its dividend by 50%. Hence, the recent expansion in MasterCard's capital deployment is also in concurrence with maintaining its market position and shareholders' confidence.
Other strong performers in the financial transaction services sector include Heartland Payment Systems Inc. (NYSE: HPY) and Total System Services Inc. (NYSE: TSS), both of which carry a Zacks Rank #2 (Buy).
Perrigo in Expansion Mode
Perrigo Company (Nasdaq: PRGO) recently announced that it is set to acquire a UK-based privately held pharmaceutical company, Rosemont Pharmaceuticals Ltd. and has entered into a definitive merger agreement for the same. The deal is valued at $283 million.
By acquiring Rosemont Pharma, Perrigo aims to strengthen its position in the UK oral liquid formulations space. Rosemont Pharma boasts of a portfolio of more than 90 products. The company generated net sales of more than $60 million in 2012.
The deal is expected to boost Perrigo's adjusted earnings in fiscal 2013 by $0.08 per share. Perrigo now expects fiscal 2013 earnings in the range of $5.53 – $5.73 per share (previous guidance: $5.45 – $5.65 per share). The Zacks Consensus Estimate of $5.56 per share is towards the lower end of the company's guidance range.
We note that Perrigo has been quite active on the acquisition front lately. In a bid to strengthen its position in the over-the-counter (OTC) retail pet healthcare market, just a few days back Perrigo inked a deal to buy animal health company Velcera, Inc. for $160 million in cash. The deal is expected to close in calendar year 2013.
In Dec 2012, Perrigo acquired privately-held Cobrek Pharmaceuticals, Inc. for approximately $45 million in cash. In Oct 2012, Perrigo had acquired the entire assets of privately-held Sergeant's Pet Care Products, Inc.
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
SOURCE Zacks Investment Research, Inc.